275 results on '"Morris, Patrick G."'
Search Results
2. Neoadjuvant trastuzumab deruxtecan (T-DXd) with response-directed definitive therapy in early stage HER2-positive breast cancer: a phase II study protocol (SHAMROCK study)
3. Predictive modelling of response to neoadjuvant therapy in HER2+ breast cancer
4. An observational study of dose dense chemotherapy with lipegfilgrastim support in early breast cancer
5. The cost of cancer care: how far would you go for a trial?
6. High frequency and mortality of head and neck malignancy in organ transplant recipients in Ireland – A national cohort study
7. COVID-19-related mortality in cancer patients in an Irish setting
8. Exhaled Breath Condensate (EBC) analysis of circulating tumour DNA (ctDNA) using a lung cancer specific UltraSEEK oncogene panel
9. Delivery of systemic anti-cancer therapy during the COVID-19 pandemic
10. Prognostic factors influencing survival following re-resection for isocitrate dehydrogenase (IDH) -wildtype glioblastoma multiforme – Data from a national neuro-oncology registry
11. Chemotherapy in the Covid-19 era: the patient’s perception
12. Pregnancy-associated breast cancer: evaluating maternal and foetal outcomes. A national study
13. Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study
14. Lack of familiarity with genetic testing among patients in Ireland with Cancer
15. Correction to: The cost of cancer care: how far would you go for a trial?
16. Targeting the PI3K and MAPK pathways to improve response to HER2-targeted therapies in HER2-positive gastric cancer
17. One year of procarbazine lomustine and vincristine is poorly tolerated in low grade glioma: a real world experience in a national neuro-oncology centre
18. Hydroxyapatite mineral enhances malignant potential in a tissue-engineered model of ductal carcinoma in situ (DCIS)
19. Patient demographics and management challenges in an Irish symptomatic breast cancer unit
20. Preclinical evaluation of a novel triple-acting PIM/PI3K/mTOR inhibitor, IBL-302, in breast cancer
21. Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast Cancer
22. Absence of thyroid transcription factor-1 expression is associated with poor survival in patients with advanced pulmonary adenocarcinoma treated with pemetrexed-based chemotherapy
23. Identification and clinical impact of potentially actionable somatic oncogenic mutations in solid tumor samples
24. Induction treatment prior to chemoradiotherapy in nasopharyngeal carcinoma: triplet or doublet chemotherapy?
25. Adjuvant Chemotherapy and Trastuzumab Is Safe and Effective in Older Women With Small, Node-Negative, HER2-Positive Early-Stage Breast Cancer
26. Biomarkers That Predict Sensitivity to Heat Shock Protein 90 Inhibitors
27. An uncommon complication of vertebroplasty: the role of anticoagulation
28. The significance of BRAF V600E mutation status discordance between primary cutaneous melanoma and brain metastases: The implications for BRAF inhibitor therapy
29. Serum N-Telopeptide and Bone-Specific Alkaline Phosphatase Levels in Patients With Osteonecrosis of the Jaw Receiving Bisphosphonates for Bone Metastases
30. Optimizing the use of anthracyclines in older patients with breast cancer
31. Bone Scans, Bisphosphonates, and a Lack of Acute Changes Within the Mandible
32. Intravenous Bisphosphonate Therapy Does Not Acutely Alter Nuclear Bone Scan Results
33. Serum metabolomic profiles evaluated after surgery may identify patients with oestrogen receptor negative early breast cancer at increased risk of disease recurrence. Results from a retrospective study
34. Therapeutic challenges in primary CNS lymphoma
35. Translating Mathematical Modeling of Tumor Growth Patterns into Novel Therapeutic Approaches for Breast Cancer
36. Problems of Research in a Stratified Little Community
37. Profile of Trastuzumab Deruxtecan in the Management of Patients with HER2-Positive Unresectable or Metastatic Breast Cancer: An Evidence-Based Review
38. Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs
39. Novel targeted agents for platelet-derived growth factor receptor and c-KIT in malignant gliomas
40. The search for novel therapeutic strategies in the treatment of recurrent glioblastoma multiforme
41. Impact of obesity on the survival of patients with early-stage squamous cell carcinoma of the oral tongue
42. Brain metastases in breast cancer
43. Emergence of MRSA in positive blood cultures from patients with febrile neutropenia—a cause for concern
44. Pilot study of 68Ga-DOTA-F(ab′)2-trastuzumab in patients with breast cancer
45. Long-term cardiac safety and outcomes of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel and trastuzumab with and without lapatinib in patients with early breast cancer
46. Standardized uptake value by positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancer
47. New Treatments for Leptomeningeal Metastases Are Urgently Needed
48. Limited Overall Survival in Patients with Brain Metastases from Triple Negative Breast Cancer
49. Adjuvant trastuzumab reduces locoregional recurrence in women who receive breast-conservation therapy for lymph node-negative, human epidermal growth factor receptor 2-positive breast cancer
50. Leptomeningeal Metastasis from Non-small Cell Lung Cancer: Survival and the Impact of Whole Brain Radiotherapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.